RenovoRx, Inc.

RNXTNASDAQHealthcare● Active

$0.90

+$0.02(+1.91%)

Market Cap$33595562

P/E Ratio—

52W High$1.45

52W Low$0.701

Avg Volume377K

Open$0.89

Beta1.00

Overview

RenovoRx, Inc.（RNXT）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · RNXT · 截至 2026年6月9日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

∞

Buy/Sell (by trades)

整体情绪

偏多

↑ Buy 100%仅显示有效交易 · 排除RSU归属0% Sell ↓

RenovoRx, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月9日

RNXT 季度内部人买卖趋势

RNXT 内幕交易卖出 · RNXT 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

1.8M901K0

2023 Q4

2024 Q1

2024 Q4

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 9, 2026

活跃内部人

近12个月交易最活跃 · RNXT CEO内幕交易

显示全部内部人 · 点击卡片过滤下方交易表

▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API

近期内幕交易记录

RNXT 高管卖出股份 · RNXT 董事内幕交易 · SEC Form 4申报

显示最近 39 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
May 19, 2026	VOLL MARK CFO	Purchase	25,000	$0.79	$20K	142,380	Form 4
Apr 3, 2026	VOLL MARK CFO	Award	80,000	—	—	117,380	Form 4
Mar 25, 2026	VOLL MARK CFO	Award	12,380	—	—	37,380	Form 4
Mar 20, 2026	Marton Laurence Director	Purchase	9,720	—	—	9,720	Form 4
Mar 20, 2026	Bagai Shaun CEO · Director	Purchase	24,300	—	—	313,357	Form 4
Mar 20, 2026	VOLL MARK CFO	Purchase	97,200	—	—	97,200	Form 4
Jan 21, 2026	Agah Ramtin Chief Medical Officer · Director	Purchase	10,000	$1.00	$10K	798,460	Form 4
Dec 31, 2025	Agah Ramtin Chief Medical Officer · Director	Purchase	9,795	$0.86	$8K	788,460	Form 4
Dec 30, 2025	Agah Ramtin Chief Medical Officer · Director	Purchase	205	$0.83	$169	778,665	Form 4
Dec 18, 2025	Bagai Shaun CEO · Director	Purchase	5,000	$0.90	$5K	340,040	Form 4
Dec 17, 2025	Bagai Shaun CEO · Director	Purchase	5,000	$0.85	$4K	335,040	Form 4
Dec 16, 2025	Agah Ramtin Chief Medical Officer · Director	Purchase	12,000	$0.85	$10K	778,460	Form 4
Dec 5, 2025	Agah Ramtin Chief Medical Officer · Director	Purchase	10,000	$0.96	$10K	766,460	Form 4
Nov 24, 2025	Agah Ramtin Chief Medical Officer · Director	Purchase	12,000	$0.80	$10K	756,460	Form 4
Nov 21, 2025	Agah Ramtin Chief Medical Officer · Director	Purchase	10,000	$0.80	$8K	744,460	Form 4
Aug 25, 2025	Bagai Shaun CEO · Director	Purchase	5,000	$0.91	$5K	330,040	Form 4
Aug 22, 2025	Bagai Shaun CEO · Director	Purchase	5,000	$0.95	$5K	325,040	Form 4
Jun 5, 2025	Agah Ramtin Chief Medical Officer · Director	Purchase	21,000	$1.40	$29K	734,460	Form 4
Apr 22, 2025	Agah Ramtin Chief Medical Officer · Director	Gift	400,000	—	—	713,460	Form 4
May 2, 2025	Marton Laurence Director	Option	20,480	$0.15	$3K	66,164	Form 4
Apr 15, 2025	Agah Ramtin Chief Medical Officer · Director	Purchase	15,000	$0.90	$14K	1,113,460	Form 4
Apr 15, 2025	Bagai Shaun CEO · Director	Purchase	7,500	$0.91	$7K	320,040	Form 4
Apr 11, 2025	Agah Ramtin Chief Medical Officer · Director	Purchase	20,000	$0.80	$16K	1,098,460	Form 4
Apr 10, 2025	Kocak Ron VP Controller and PAO	Purchase	6,500	$0.79	$5K	12,595	Form 4
Apr 9, 2025	Kocak Ron VP Controller and PAO	Purchase	6,000	$0.80	$5K	6,095	Form 4

VOLL MARK

CFO

Purchase

日期

May 19

股数

25,000

均价

$0.79

总金额

$20K

View Form 4 on SEC.gov

VOLL MARK

CFO

Award

日期

Apr 3

股数

80,000

均价

—

总金额

—

View Form 4 on SEC.gov

VOLL MARK

CFO

Award

日期

Mar 25

股数

12,380

均价

—

总金额

—

View Form 4 on SEC.gov

Marton Laurence

Director

Purchase

日期

Mar 20

股数

9,720

均价

—

总金额

—

View Form 4 on SEC.gov

Bagai Shaun

CEO · Director

Purchase

日期

Mar 20

股数

24,300

均价

—

总金额

—

View Form 4 on SEC.gov

VOLL MARK

CFO

Purchase

日期

Mar 20

股数

97,200

均价

—

总金额

—

View Form 4 on SEC.gov

Agah Ramtin

Chief Medical Officer · Director

Purchase

日期

Jan 21

股数

10,000

均价

$1.00

总金额

$10K

View Form 4 on SEC.gov

Agah Ramtin

Chief Medical Officer · Director

Purchase

日期

Dec 31

股数

9,795

均价

$0.86

总金额

$8K

View Form 4 on SEC.gov

Agah Ramtin

Chief Medical Officer · Director

Purchase

日期

Dec 30

股数

205

均价

$0.83

总金额

$169

View Form 4 on SEC.gov

Bagai Shaun

CEO · Director

Purchase

日期

Dec 18

股数

5,000

均价

$0.90

总金额

$5K

View Form 4 on SEC.gov

Bagai Shaun

CEO · Director

Purchase

日期

Dec 17

股数

5,000

均价

$0.85

总金额

$4K

View Form 4 on SEC.gov

Agah Ramtin

Chief Medical Officer · Director

Purchase

日期

Dec 16

股数

12,000

均价

$0.85

总金额

$10K

View Form 4 on SEC.gov

Agah Ramtin

Chief Medical Officer · Director

Purchase

日期

Dec 5

股数

10,000

均价

$0.96

总金额

$10K

View Form 4 on SEC.gov

Agah Ramtin

Chief Medical Officer · Director

Purchase

日期

Nov 24

股数

12,000

均价

$0.80

总金额

$10K

View Form 4 on SEC.gov

Agah Ramtin

Chief Medical Officer · Director

Purchase

日期

Nov 21

股数

10,000

均价

$0.80

总金额

$8K

View Form 4 on SEC.gov

Bagai Shaun

CEO · Director

Purchase

日期

Aug 25

股数

5,000

均价

$0.91

总金额

$5K

View Form 4 on SEC.gov

Bagai Shaun

CEO · Director

Purchase

日期

Aug 22

股数

5,000

均价

$0.95

总金额

$5K

View Form 4 on SEC.gov

Agah Ramtin

Chief Medical Officer · Director

Purchase

日期

Jun 5

股数

21,000

均价

$1.40

总金额

$29K

View Form 4 on SEC.gov

Agah Ramtin

Chief Medical Officer · Director

Gift

日期

Apr 22

股数

400,000

均价

—

总金额

—

View Form 4 on SEC.gov

Marton Laurence

Director

Option

日期

May 2

股数

20,480

均价

$0.15

总金额

$3K

View Form 4 on SEC.gov

Agah Ramtin

Chief Medical Officer · Director

Purchase

日期

Apr 15

股数

15,000

均价

$0.90

总金额

$14K

View Form 4 on SEC.gov

Bagai Shaun

CEO · Director

Purchase

日期

Apr 15

股数

7,500

均价

$0.91

总金额

$7K

View Form 4 on SEC.gov

Agah Ramtin

Chief Medical Officer · Director

Purchase

日期

Apr 11

股数

20,000

均价

$0.80

总金额

$16K

View Form 4 on SEC.gov

Kocak Ron

VP Controller and PAO

Purchase

日期

Apr 10

股数

6,500

均价

$0.79

总金额

$5K

View Form 4 on SEC.gov

Kocak Ron

VP Controller and PAO

Purchase

日期

Apr 9

股数

6,000

均价

$0.80

总金额

$5K

View Form 4 on SEC.gov

⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股

1 / 2

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 RNXT 内幕交易

RNXT 内幕交易

RenovoRx, Inc.（RNXT）内幕交易数据来源于公司内部人（包括Agah Ramtin (Chief Medical Officer · Director), Bagai Shaun (CEO · Director), VOLL MARK (CFO)）提交的SEC Form 4申报文件。过去12个月内，4位内部人向SEC提交了交易申报。RNXT内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看RenovoRx, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

RNXT 内幕交易 · 5个问题

RenovoRx, Inc.（RNXT）的内部人包括高管和董事，如Agah Ramtin (Chief Medical Officer · Director), Bagai Shaun (CEO · Director), VOLL MARK (CFO)等。过去12个月内，4位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

RNXT 董事内幕交易RNXT 内部人名单RenovoRx, Inc. 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026